Amgen’s treatment of biliary tract cancers was granted orphan status by the FDA, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AMGN:
- Amgen (NASDAQ:AMGN) Gains on New AWS Partnership
- Fly Insider: Air Products, Amgen among this week’s notable insider trades
- Harpoon Therapeutics initiated with an Outperform at TD Cowen
- Homology Medicines, Q32 Bio enter all-stock merger agreement
- Eli Lilly (NYSE:LLY) Slips despite Good News on Heart Drug
